Jersey City, New Jersey Clinical Trials

A listing of Jersey City, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 384 clinical trials
Yoga for Anxiety in Adults

The purpose of this study is to investigate the effect of a telerehabilitation-yoga intervention delivered remotely via videoconferencing on adults with Parkinson's Disease and anxiety symptoms.

anxiety
anxiety symptoms
parkinson's disease
Rutgers University
 (6.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

metastasis
measurable disease
metastatic cancer
rimiducid
metastatic disease
Memorial Sloan Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Lorenc Aesthetic Plastic Surgery Center
 (7.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
GutMe!: IBS and Collagen Protein Powder an Interventional Study

In this study we would like to understand how or if a food-based supplement affects gut symptoms such as bloating, stomach cramps and irregular bowel habits. Through using a digital symptom tracking app for a few weeks, you may just learn more about exactly what is triggering your symptoms!

gut symptoms
bloating
spasm
ProofPilot (Virtual Study: https://p.proofpilot.com)
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in two phases. Phase 1a of this …

myelodysplastic syndrome
exhaustion
cancer therapy
recurrent disease
refractory acute myeloid leukemia (aml)
Memorial Sloan-Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

This phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to other parts of the body (localized). High-dose rate brachytherapy delivers radiation directly into the prostate within a few minutes by a single radioactive seed through …

computed tomography
adjuvant
androgen deprivation therapy
stage iia prostate cancer
stage iib prostate cancer
Rutgers New Jersey Medical School
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

BRAF
pembrolizumab
metastasis
stage iv non-small cell lung cancer
adjuvant
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (6.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +27 other locations
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

nivolumab
lung adenocarcinoma
tubal ligation
hysterectomy
lung cancer
Icahn School of Medicine at Mount Sinai
 (7.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
ATR Inhibitor BAY 1895344 Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer

The purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with BAY1895344 in combination with niraparib. In addition researchers want to find for patients the optimal dose of BAY1895344 in combination with niraparib, how the drug is tolerated and …

metastasis
neutrophil count
ovarian cancer
prostate cancer
ATR
Memorial Sloan-Kettering Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

pembrolizumab
stage iv non-small cell lung cancer
lymphoma
egf receptors
venetoclax
NYU Langone - Laura and Isaac Perlmutter Cancer Center /ID# 218077
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +38 other locations